A dilemma no mother-to-be should face
31 January 2018
Clair faced an impossible choice – risk delivering her baby early, or delay potentially life-saving melanoma treatment.
She was 38 weeks’ pregnant with her first child when she received the news that a suspicious looking mole on her face was melanoma. Her medical team advised her she needed urgent surgery to remove the melanoma.
“It was pretty scary,” Clair said. “We discussed getting me into surgery that week but that would require knocking me out and with that there was a great risk of me going into labour in the operating theatre and waking up with my baby. That wasn’t something I wanted.”
Luckily, Clair and her medical team were able to formulate a plan which enabled her to give birth to her son and then have the surgery shortly afterwards.
“You’re breast feeding at the time, you have to fast for the surgery, you’re away from your baby - you have all those fears running through your mind,” Clair recalls.
Clair’s surgery was a success and she has since had three more children. She is grateful her employer, Brightside Cover, is supporting melanoma research by coming on board as Principal Partner for Melanoma March.
Clair’s is the latest in a series of emotive videos launched by Melanoma Institute Australia, showing the impact of melanoma on everyday Australians. Watch her story here and join her in the fight against melanoma by signing up for a Melanoma March event near you.
Sydney Health Partners' goal is to ensure world class research is successfully implemented & scaled-up to benefit patients & wider society.
Jana Pittman and Melinda Gainsford-Taylor urge Australians to be sun-safe and check their skin as they join the Game On Mole campaign in support of their much-loved coach
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
Honouring the exceptional impact of his work on communities around the world.
MIA's Co-Medical Directors receive University of Sydney's Vice-Chancellor's Award for Outstanding Research
Awarded for their life-saving discoveries transforming melanoma patient care.
National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment
Recognising her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.
Clinicians and researchers from across Australia and beyond united online, bringing the AMC2021 conference theme of Promising Futures to life.
Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.
MIA is proud to announce that five of our researchers have been named on the Clarivate Annual Highly Cited Researchers™ 2021 list.
New research shows routine skin checks by a health professional, coupled with checking your own skin, are vital in saving lives from melanoma.
With new patient figures indicating people may have deferred skin checks during the pandemic our Game On Mole campaign is more important than ever.
We are excited to announce a return to our much-loved physical Melanoma March events in March 2022!
Read more about the wonderful MIA community fundraising initiatives held recently.
Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread
Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!
Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.
Three MIA researchers at University of Sydney received grants to further their important melanoma research.
COVID restrictions continue to impact fundraising for melanoma services in Riverina.
Ben Garrow lost his life to melanoma. In his honour his family has established a scholarship to support a PhD student whose work focuses on saving lives from melanoma.